Rafarm S.a. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Rafarm S.a.

Patent Number:
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
Opposition Date:
Nov 9, 2022

Competitors of Rafarm S.a.

NOVARTIS AG

Want to track Rafarm S.a.?

Feel free to send us a message here and we will get back to you